Brought to you by 
Merck sells OTC operations to Bayer for $14.2bn
May 2014
Executive Summary
Edging out other rumored bidders including Reckitt Benckiser and Procter & Gamble, Bayer AG acquired Merck & Co. Inc.’s consumer business for $14.2bn. A portion of that payment is related to sales of Merck’s allergy product Claritin and Afrin nasal decongestant spray in certain countries where they are still only available via prescriptions.
Deal Industry
-
Pharmaceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Merck sells OTC operations to Bayer for $14.2bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice